Product Details
Composition
Bendamustine Hydrochloride IP
Dosage Form
Lyophilized Injection
Route Of Administration
IV Infusion
Vial Type
Single Dose Vial
Reconstitution
20ml Sterile Water For Injection
Further Dilution
0.9% Sodium Chloride / 2.5% Dextrose Solution
Therapeutic Class
Antineoplastic
Drug Class
Alkylating Agent
Indication
Chronic Lymphocytic Leukemia
Additional Indication
Non-Hodgkin Lymphoma
Light Protection
Protect From Light
Manufacturer
Biomak Laboratories Pvt. Ltd.
Prescription
Schedule H Prescription Drug
Special Handling
Cytotoxic Medicine
Our Makmustine Bendamustine 100mg Injection is a top choice for pharmaceutical companies seeking high-quality antineoplastic products. Each 100mg/vial comes in a convenient glass vial in carton packaging, ensuring safe storage and easy handling. The Bendamustine Hydrochloride IP composition guarantees efficacy, while the lyophilized form allows for IV infusion. This single-dose vial requires reconstitution with 20ml sterile water for injection and further dilution with 0.9% sodium chloride or 2.5% dextrose solution. Ideal for manufacturers, exporters, and suppliers in the industry, our Makmustine Bendamustine Injection is a reliable solution for oncology treatments.